Literature DB >> 36002565

Jejunum-derived NF-κB reporter organoids as 3D models for the study of TNF-alpha-induced inflammation.

Hellen Daghero1, Flora Doffe2, Belén Varela3, Victoria Yozzi3, José Manuel Verdes3, Martina Crispo4, Mariela Bollati-Fogolín5, Romina Pagotto6.   

Abstract

Inflammation is an important process for epithelial barrier protection but when uncontrolled, it can also lead to tissue damage. The nuclear factor-kappa light chain enhancer of activated B cells (NF-κB) signaling pathway is particularly relevant in the intestine, as it seems to play a dual role. Whereas NF-κB protects intestinal epithelium against various noxious stimuli, the same pathway mediates intestinal inflammatory diseases by inducing pro-inflammatory gene expression. The availability of appropriate in vitro models of the intestinal epithelium is crucial for further understanding the contribution of NF-κB in physiological and pathological processes and advancing in the development of drugs and therapies against gut diseases. Here we established, characterized, and validated three-dimensional cultures of intestinal organoids obtained from biopsies of NF-κB-RE-Luc mice. The NF-κB-RE-Luc intestinal organoids derived from different intestine regions recreated the cellular composition of the tissue and showed a reporter responsiveness similar to the in vivo murine model. When stimulated with TNF-α, jejunum-derived NF-κB-RE-Luc-reporter organoids, provided a useful model to evaluate the anti-inflammatory effects of natural and synthetic compounds. These reporter organoids are valuable tools to explore the epithelial TNF-α-induced NF-κB contribution in the small intestine, being a reliable alternative method while helping to reduce the use of laboratory animals for experimentation.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36002565     DOI: 10.1038/s41598-022-18556-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  2 in total

Review 1.  The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease.

Authors:  Huiyu Wang; Chunli Zhou; Junxiang Huang; Xiaoyi Kuai; Xinyu Shao
Journal:  Am J Transl Res       Date:  2020-05-15       Impact factor: 4.060

Review 2.  Interaction between the gut microbiome and mucosal immune system.

Authors:  Na Shi; Na Li; Xinwang Duan; Haitao Niu
Journal:  Mil Med Res       Date:  2017-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.